DIA458.78-1.29 -0.28%
SPX6,606.76-8.52 -0.13%
IXIC22,333.96-14.79 -0.07%

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga·09/16/2025 17:07:35
Listen to the news

Gainers

  • Co-Diagnostics (NASDAQ:CODX) shares moved upwards by 51.3% to $0.53 during Tuesday's regular session. The market value of their outstanding shares is at $13.6 million.
  • Sonnet BioTherapeutics (NASDAQ:SONN) shares moved upwards by 27.63% to $7.07. The market value of their outstanding shares is at $37.8 million.
  • Adaptimmune Therapeutics (NASDAQ:ADAP) stock increased by 27.47% to $0.08. The company's market cap stands at $17.6 million.
  • Kalaris Therapeutics (NASDAQ:KLRS) stock rose 23.71% to $4.59. The company's market cap stands at $69.3 million.
  • Apollomics (NASDAQ:APLM) shares increased by 23.25% to $11.45. The market value of their outstanding shares is at $19.9 million.
  • Kindly MD (NASDAQ:NAKA) shares increased by 20.96% to $1.5. The market value of their outstanding shares is at $466.3 million.

Losers

  • Bionano Genomics (NASDAQ:BNGO) stock decreased by 39.7% to $1.67 during Tuesday's regular session. The company's market cap stands at $12.9 million.
  • VivoSim Labs (NASDAQ:VIVS) stock fell 26.3% to $3.52. The market value of their outstanding shares is at $12.4 million.
  • bioAffinity Technologies (NASDAQ:BIAF) stock decreased by 23.89% to $0.27. The company's market cap stands at $9.9 million.
  • NanoVibronix (NASDAQ:NAOV) shares fell 21.78% to $8.37. The market value of their outstanding shares is at $8.5 million.
  • NovaBay Pharmaceuticals (AMEX:NBY) shares declined by 21.17% to $2.16. The company's market cap stands at $15.9 million.
  • MetaVia (NASDAQ:MTVA) stock declined by 20.01% to $1.2. The market value of their outstanding shares is at $36.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.